Literature DB >> 16189297

Activation of adenylyl cyclase by endogenous G(s)-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT(7) receptor expression.

Kjetil Wessel Andressen1, Jens Henrik Norum, Finn Olav Levy, Kurt A Krobert.   

Abstract

Human 5-hydroxytryptamine(7) (5-HT(7)) receptors display characteristics shared with receptors believed to form a tight physical coupling with G protein in the absence of ligand. Some receptors apparently preassociated with G(i/o) and G(q/11) are reported to inhibit the signaling of other similarly coupled G protein-coupled receptors by limiting their access to activate a common G protein pool. Therefore, we determined whether 5-HT(7) receptor expression was sufficient to limit signaling of endogenously expressed G(s)-coupled receptors in human embryonic kidney (HEK) 293 cells. Using the ecdysone-inducible expression system, which allows for the titration of increasing receptor density in the same clonal cell line, we compared the effects of 5-HT(4(b)) and 5-HT(7(a,b,d)) receptor expression on adenylyl cyclase (AC) stimulation by the endogenous G(s)-coupled beta-adrenergic (betaAR) and prostanoid EP (EPR) receptors. betaAR- and EPR-stimulated AC activity was attenuated by 5-HT(7) receptor expression in both membrane preparations and intact HEK293 cells. betaAR- and EPR-stimulated AC activity was unaffected by expression of the G(s)-coupled 5-HT(4) receptor. The mechanism of this heterologous desensitization seems independent of protein kinase A activation, nor does it occur at the level of G protein activation because 1) betaAR- and EPR-stimulated AC activity was not restored to control values when Galpha(s) was overexpressed; and 2) beta(1)AR and beta(2)AR activation of Galpha(s) was unaffected by the expression of 5-HT(7) receptors. In addition, overexpression of AC isoforms was unable to rescue betaAR- and EPR-stimulated AC activity. Therefore, 5-HT(7) receptors probably limit access and/or impede activation of AC by betaAR and EP receptors. Although the 5-HT(7) receptor may preassociate with G protein and/or AC, the mechanism of this heterologous desensitization remains elusive.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189297     DOI: 10.1124/mol.105.015396

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  15 in total

1.  Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect.

Authors:  M T Klein; M Teitler
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 2.  GPCR and G proteins: drug efficacy and activation in live cells.

Authors:  Jean-Pierre Vilardaga; Moritz Bünemann; Timothy N Feinstein; Nevin Lambert; Viacheslav O Nikolaev; Stefan Engelhardt; Martin J Lohse; Carsten Hoffmann
Journal:  Mol Endocrinol       Date:  2009-02-05

3.  A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling.

Authors:  Monica Soto-Velasquez; Michael P Hayes; Aktan Alpsoy; Emily C Dykhuizen; Val J Watts
Journal:  Mol Pharmacol       Date:  2018-06-27       Impact factor: 4.436

4.  Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form.

Authors:  Maria Rosario Tubio; Natalia Fernandez; Carlos Patricio Fitzsimons; Sabrina Copsel; Sergio Santiago; Carina Shayo; Carlos Davio; Federico Monczor
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

5.  Tandem Mass Tag Labeling Facilitates Reversed-Phase Liquid Chromatography-Mass Spectrometry Analysis of Hydrophilic Phosphopeptides.

Authors:  Chia-Feng Tsai; Jeffrey S Smith; Krzysztof Krajewski; Rui Zhao; Ahmed M Moghieb; Carrie D Nicora; Xinyu Xiong; Ronald J Moore; Tao Liu; Richard D Smith; Jon M Jacobs; Sudarshan Rajagopal; Tujin Shi
Journal:  Anal Chem       Date:  2019-08-28       Impact factor: 6.986

Review 6.  The serotonin 5-HT7 receptors: two decades of research.

Authors:  Evelien Gellynck; Karen Heyninck; Kjetil W Andressen; Guy Haegeman; Finn Olav Levy; Peter Vanhoenacker; Kathleen Van Craenenbroeck
Journal:  Exp Brain Res       Date:  2013-09-17       Impact factor: 1.972

7.  Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system.

Authors:  T A Barnes; J McDonald; D J Rowbotham; T L Duarte; D G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-25       Impact factor: 3.000

8.  Receptor-G protein interaction studied by bioluminescence resonance energy transfer: lessons from protease-activated receptor 1.

Authors:  Mohammed Akli Ayoub; Abdulrahman Al-Senaidy; Jean-Philippe Pin
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-22       Impact factor: 5.555

9.  Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons.

Authors:  Maryam S Vasefi; Kai Yang; Jerry Li; Jeff S Kruk; John J Heikkila; Michael F Jackson; John F MacDonald; Michael A Beazely
Journal:  Mol Brain       Date:  2013-05-14       Impact factor: 4.041

10.  Human 5-HT(4) and 5-HT(7) receptor splice variants: are they important?

Authors:  Ian M Coupar; Paul V Desmond; Helen R Irving
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.